Trevena reports completion of TRV027 Phase 2a study in advanced heart failure … – News-Medical.net
Trevena reports completion of TRV027 Phase 2a study in advanced heart failure …News-Medical.netTrevena, Inc., the leader in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced that it has successfully co…